Gross Margin

All eyes are on Micron's March 18 report as a key test of the AI-fueled memory market recovery and the firm's strategic pivot to high-value tech.

onsemi will detail its long-term financial and innovation roadmap, focusing on capitalizing on AI, EV, and industrial megatrends amid fierce competition.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

The legacy brand blends heritage, market strategy, and conservation with its new 8-year bourbon, inspired by 19th-century decanters and now available nationwide.

PGA star Max Homa shares his hidden health battle with seborrheic dermatitis, urging millions to trade self-diagnosis for a doctor's visit.

Medtronic's diabetes arm hits the road for its IPO, seeking to raise up to $784M in a major test of investor appetite for specialized medtech firms.

The maker of Wegovy and Ozempic announces a massive price cut. We explore what this means for patients, competitors, and the future of drug pricing.

Cell and gene therapy manufacturer OXB posts a dramatic turnaround to profitability, with surging revenues and an ambitious forecast for the coming years.

The shipping and printing giant's spot on a top global list highlights a stable model for entrepreneurs and its vital role in supporting small businesses.

Apellis Pharmaceuticals reports its first profitable year on strong SYFOVRE and EMPAVELI sales, but faces pressure to maintain momentum amid competition.

The powertrain giant crushed market expectations with a 29% revenue surge in 2025, fueled by heavy-duty engines, while eyeing a global and green future.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

The department store chain reported strong earnings that surpassed analyst estimates, but declining sales and margin pressure reveal a complex path forward.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

As Mueller Water Products heads to a key industry symposium, a new CEO and record earnings set the stage for its vision for America's water future.

UMortgage is betting on a radical flat-fee structure with a production cap, aiming to attract top talent and accelerate the industry's shift to brokers.

Renoworks strengthens its board with a tech investment expert, signaling a strategic push to scale its AI platform and capitalize on the digital home market.

Satellogic launches its Aleph Observer service, shifting the satellite industry from ad-hoc snapshots to persistent, large-scale global monitoring.

With a $2.5B valuation and new brand, Mews is betting its unified platform can solve hospitality's biggest problems: fragmentation and inefficiency.

With key investor conferences looming, Phathom Pharmaceuticals is set to showcase strong VOQUEZNA sales and a clear path to 2026 profitability.